Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Journal of Cancer Research and Clinical Oncology|July 17, 2023
The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancerSarah Maloney, Stephen J Clarke, Sumit Sahni, et al.
Cancers|May 28, 2020
Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?Josef Gillson, Yogambha Ramaswamy, Gurvinder Singh, et al.
Free Radical Biology & Medicine|July 27, 2011
Dinitrosyliron complexes are the most abundant nitric oxide-derived cellular adduct: biological parameters of assembly and disappearanceJason R Hickok, Sumit Sahni, Hong Shen, et al.
International Journal of Cancer|March 23, 2024
Novel serum protein biomarker panel for early diagnosis of pancreatic cancerSooin Byeon, Matthew J McKay, Mark P Molloy, et al.
Cancer Medicine|August 4, 2023
Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single-cell analysisSooin Byeon, Taymin du Toit-Thompson, Josef Gillson, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 22, 2018
Identification of differential phosphorylation and sub-cellular localization of the metastasis suppressor, NDRG1Kyung Chan Park, Sharleen V Menezes, Danuta S Kalinowski, et al.
Biochimica Et Biophysica Acta. General Subjects|April 27, 2020
NDRG1 suppresses basal and hypoxia-induced autophagy at both the initiation and degradation stages and sensitizes pancreatic cancer cells to lysosomal membrane permeabilizationSumit Sahni, Josef Gillson, Kyung Chan Park, et al.
Cancer Medicine|December 11, 2024
Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasms of the PancreasWilliam A Ziaziaris, Christopher S H Lim, Loretta Sioson, et al.
Biochimica Et Biophysica Acta. General Subjects|July 30, 2021
Urinary metabolite prognostic biomarker panel for pancreatic ductal adenocarcinomasLuke Hipperson, William J Hadden, Christopher B Nahm, et al.
Molecular Pharmacology|January 7, 2015
Novel thiosemicarbazones regulate the signal transducer and activator of transcription 3 (STAT3) pathway: inhibition of constitutive and interleukin 6-induced activation by iron depletionGoldie Y L Lui, Zaklina Kovacevic, Sharleen V Menezes, et al.
Pageof 9